论文部分内容阅读
目的探讨婴幼儿肺炎支原体肺炎临床的特征及治疗对策。方法选择我院2011年5月-2013年2月儿科收治的200例肺炎患儿,确诊为肺炎支原体肺炎100例为观察组,非肺炎支原体肺炎100例为对照组,分别检测血常规、CRP、肝肾功能、心肌酶、胸片、MP-IgM,比较分析临床症状、肺部X线表现、肺外表现,用大环内酯类药物治疗婴幼儿支原体肺炎。结果观察组患儿气喘、心肌酶增高、肝功能异常发生率明显高于对照组、白细胞增高发生率明显低于对照组、治疗3d后仍发热的病例数明显多于对照组;观察组肺部X线表现以肺门阴影增浓为主,对照组则以小斑片状阴影为主;观察组对大环内酯类药物治疗效果较好。结论婴幼儿支原体肺炎的临床特点主要是X线肺门阴影增浓,早期规范大环内酯类抗生素的治疗,对及时控制临床症状、预防复发有重要意义。
Objective To investigate the clinical characteristics and treatment of Mycoplasma pneumoniae pneumonia in infants and children. Methods A total of 200 cases of children with pneumonia admitted to our hospital from May 2011 to February 2013 were selected as the observation group and 100 cases of non-Mycoplasma pneumoniae pneumonia as the control group. The levels of CRP, Liver and kidney function, myocardial enzymes, chest radiograph, MP-IgM, comparative analysis of clinical symptoms, pulmonary X-ray findings, extrapulmonary manifestations, with macrolide drug treatment of infantile mycoplasma pneumonia. Results The incidences of asthma, myocardial enzymes and abnormal liver function in observation group were significantly higher than those in control group. The incidence of leukocytosis in observation group was significantly lower than that in control group. The number of cases with fever after treatment for 3d was more than that in control group. X-ray showed hilar thickening dominated, the control group is dominated by small patchy shadows; observation group of macrolide drug treatment is better. Conclusion The main clinical features of mycoplasma pneumonia in infants and young children are the thickening of the hilar shadow of the X-ray and early treatment of macrolide antibiotics, which is of great significance for the timely control of clinical symptoms and prevention of recurrence.